CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 95 enrolled
Drug / intervention
HiBalance +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03213873
NCT03213873N/ACompleted

Effects of the HiBalance-program: Linking Clinical Signs and Symptoms to Changes in the Brain in People With Parkinson´s Disease

Karolinska Institutet·interventional·Posted Jul 11, 2017·Updated Mar 7, 2025

In Brief

A clinical study evaluating HiBalance and Speech and communication therapy for Parkinson Disease and 3 related conditions. Completed, enrolled 95 participants across 1 site.

Detailed Summary

This project aims to determine the effects of the HiBalance program on neuroplastic changes in people with mild to moderate Parkinson´s disease. The main hypothesis is that highly challenging exercise will lead to greater gait and balance ability, increased levels of physical activity and an improved health related quality of life. The investigators further hypothesize that neuroplasticity changes will be seen in corresponding areas of the brain, neuropsychological changes on cognitive test measures, and that exercise will inhibit the degeneration of dopaminergic neurons in the brain through the mediation of neurotrophic factors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSweden

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 11, 2017
Enrollment StartAug 15, 2017
Primary CompletionDec 13, 2019
Study CompletionDec 23, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 9.0 years ago

Interventions

HiBalancebehavioral

Intervention of highly challenging balance training for 10 weeks.

Speech and communication therapybehavioral

Intervention conducted by speech and language therapist for 10 weeks.